{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:00:38Z","timestamp":1792785638150,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803423"],"award-info":[{"award-number":["81803423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Zhejiang","award":["LQ18D060005"],"award-info":[{"award-number":["LQ18D060005"]}]},{"name":"China Scholarship Council-Local cooperation project","award":["201808330623"],"award-info":[{"award-number":["201808330623"]}],"id":[{"id":"https:\/\/ror.org\/04atp4p48","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Specific research project of Guangxi for research bases and talents","award":["AD18126005"],"award-info":[{"award-number":["AD18126005"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong","doi-asserted-by":"publisher","award":["ZR2018BB024"],"award-info":[{"award-number":["ZR2018BB024"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejmech.2019.01.047","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T19:09:52Z","timestamp":1548529792000},"page":"206-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":278,"special_numbering":"C","title":["Triazole derivatives and their antiplasmodial and antimalarial activities"],"prefix":"10.1016","volume":"166","author":[{"given":"Xue-Mei","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Kai","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Lai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.01.047_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazoles as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: an overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejmech.2018.08.040","article-title":"A\u00a0review on diverse heterocyclic compounds as the previledged scaffolds in antimalarial drug discovery","volume":"158","author":"Kalaria","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-397900-1.00003-7","article-title":"Plasmodium vivax: clinical spectrum, risk factors and pathogenesis","volume":"80","author":"Anstey","year":"2012","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.ejmech.2019.01.047_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(18)30596-6","article-title":"Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis","volume":"19","author":"Commons","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.01.047_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2015.02.002","article-title":"Quinine conjugates and quinine analogues as potential antimalarial agents","volume":"97","author":"Jones","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib8","series-title":"World Malaria Report","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ejmech.2019.01.047_bib9","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","article-title":"Malaria","volume":"391","author":"Ashley","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.01.047_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.01.047_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2010.10.038","article-title":"Triazoles and tetrazoles: prime ligands to generate remarkable coordination materials","volume":"255","author":"Aromi","year":"2011","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.01.047_bib12","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.01.047_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib14","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1016\/j.ejmech.2009.06.031","article-title":"Synthesis and antimicrobial activities of novel quinoline derivatives carrying 1,2,4-triazole moiety","volume":"44","author":"Eswaran","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: design, synthesis and in\u00a0vitro anti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jhet.3112","article-title":"Coumarin-triazole hybrids and their biological activities","volume":"55","author":"Fan","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2016.09.023","article-title":"Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities","volume":"125","author":"Akhtar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijantimicag.2017.04.006","article-title":"Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges","volume":"50","author":"Roy","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.01.047_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: an overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jhet.3234","article-title":"Quinolone-triazole hybrids and their biological activities","volume":"55","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.01.047_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrids molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib24","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1016\/j.bmc.2014.12.018","article-title":"Quinoline-based antimalarial hybrid compounds","volume":"23","author":"Vandekerckhove","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib25","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2013.08.046","article-title":"In\u00a0vitro antimalarial activity, \u03b2-haematin inhibition and structure-activity relationships in a series of quinoline triazoles","volume":"69","author":"Joshi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib27","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1016\/j.bmc.2015.06.044","article-title":"In\u00a0vitro antiplasmodial activity of triazole-linked chloroquinoline derivatives synthesized from 7-chloro-N-(prop-2-yn-1-yl)quinolin-4-amine","volume":"23","author":"Taleli","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib28","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.bmc.2016.05.060","article-title":"Synthesis, antimalarial properties and 2D-QSAR studies of novel triazole-quinine conjugates","volume":"24","author":"Faidallah","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/cb4008953","article-title":"Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P.\u00a0falciparum","volume":"9","author":"Hrycyna","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.01.047_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0285.2011.01115.x","article-title":"Synthesis of 4-aminoquinoline-1,2,3-triazole and 4-aminoquinoline-1,2,3-triazole-1,3,5-triazine hybrids as potential antimalarial agents","volume":"78","author":"Manohar","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.01.047_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmech.2013.11.022","article-title":"7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studies","volume":"73","author":"Pereira","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cbdd.12321","article-title":"New compounds hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falciparum","volume":"84","author":"Boechat","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.01.047_bib33","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1016\/j.bmcl.2014.10.015","article-title":"Synthesis of novel triazole-linked mefloquine derivatives: biological evaluation against Plasmodium falciparum","volume":"24","author":"Hamann","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib34","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1002\/slct.201801905","article-title":"Synthesis and antimalarial evaluation of [1,2,3]-triazole-tethered sulfonamide-berberine hybrids","volume":"3","author":"Batra","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2019.01.047_bib35","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ejmech.2016.11.025","article-title":"Comprehensive review on various strategies for antimalarial drug discovery","volume":"125","author":"Mishra","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejmech.2012.02.006","article-title":"Synthesis and in\u00a0vitro antiplasmodial activities of fluoroquinolone analogs","volume":"51","author":"Dixit","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib37","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1002\/jhet.1822","article-title":"Quinolone analogues 15: synthesis and antimalarial activity of 4-phenyl-1-(1-triazolylmethyl-4-quinolon-3-ylcarbonyl)semicarbazide and related compounds","volume":"51","author":"Kurasawa","year":"2014","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib38","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1021\/jm030781p","article-title":"Docking and database screening reveal new classes of Plasmodium falciparum dihydrofolate reductase inhibitors","volume":"46","author":"Rastelli","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: an overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.025","article-title":"Benzufuran derivatives and their anti-tubercular, anti-bacterial activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib41","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"28","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.01.047_bib43","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmcl.2017.07.023","article-title":"Design, synthesis and in\u00a0vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jhet.3004","article-title":"Design, synthesis, and in\u00a0vitro anti-mycobacterial evaluation of propylene-1H-1,2,3-triazole-4-methylene-tethered (thio)semicarbazone-isatin-moxifloxacin hybrids","volume":"55","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib45","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00044-014-1195-6","article-title":"Insights into activity enhancement of 4-aminoquinoline-based hybrids using atom-based and field-based QSAR studies","volume":"24","author":"Raj","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.01.047_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ja.2012.113","article-title":"Antimalarial C-9 oxime derivatives from desmycosin, produced by click chemistry","volume":"66","author":"Tsutsui","year":"2013","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2019.01.047_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ja.2010.124","article-title":"In\u00a0vitro and in\u00a0vivo antimalarial activity of puberulic acid and its new analogs, viticolins A-C, produced by Penicillium sp. FKI-4410","volume":"64","author":"Iwatsuki","year":"2011","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2019.01.047_bib48","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.56.727","article-title":"In\u00a0vitro and in\u00a0vivo antimalarial activities of a non-glycosidic 18-membered macrolide antibiotic, borrelidin, against drug-resistant strains of Plasmodia","volume":"56","author":"Otoguro","year":"2003","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2019.01.047_bib49","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.bmcl.2013.02.075","article-title":"Borrelidin analogues with antimalarial activity: design, synthesis and biological evaluation against Plasmodium falciparum parasites","volume":"23","author":"Sugawara","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib50","first-page":"551","article-title":"Synthesis, in\u00a0vitro antimalarial activity and in silico studies of hybrid kauranoid 1,2,3-triazoles derived from naturally occurring diterpenes","volume":"27","author":"Santo","year":"2016","journal-title":"J.\u00a0Braz. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.01.047_bib51","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.compbiolchem.2018.08.003","article-title":"Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies","volume":"76","author":"Shah","year":"2018","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib52","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phytochem.2016.12.009","article-title":"Antiplasmodial dimeric chalcone derivatives from the roots of Uvaria siamensis","volume":"135","author":"Salae","year":"2017","journal-title":"Photochemistry"},{"key":"10.1016\/j.ejmech.2019.01.047_bib53","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ejmech.2007.09.014","article-title":"Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in\u00a0vitro","volume":"43","author":"Mishra","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib54","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1016\/j.bmc.2010.10.009","article-title":"Design, synthesis and in\u00a0vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds","volume":"18","author":"Guantai","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib55","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ejmech.2017.07.041","article-title":"4-Aminoquinoline-chalcone\/-N-acetylpyrazoline conjugates: synthesis and antiplasmodial evaluation","volume":"138","author":"Kumar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2016.09.044","article-title":"4-Aminoquinoline-ferrocenyl-chalcone conjugates: synthesis and anti-plasmodial evaluation","volume":"125","author":"Singh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib57","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1016\/j.tet.2012.04.011","article-title":"Synthesis of novel \u03b2-lactams bearing an anthraquinone moiety, and evaluation of their antimalarial activities","volume":"68","author":"Jarrahpour","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.01.047_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2013.10.079","article-title":"Urea\/oxalamide tethered \u03b2-lactam-7-chloroquinoline conjugates: synthesis and in\u00a0vitro antimalarial evaluation","volume":"71","author":"Singh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib59","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bmcl.2011.11.082","article-title":"Synthesis, docking and in\u00a0vitro antimalarial evaluation of bifunctional hybrids derived from \u03b2-lactams and 7-chloroquinoline using click chemistry","volume":"22","author":"Singh","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluoroquinolone-isatin hybrids and their biological activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib61","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","article-title":"Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jhet.3189","article-title":"Isatin derivatives with potential antitubercular activities","volume":"55","author":"Jiang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib63","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bmcl.2013.12.109","article-title":"1H-1,2,3-Triazole-tethered isatin-7-chloroquinoline and 3-hydroxy-indole-7-chloroquinoline conjugates: synthesis and antimalarial evaluation","volume":"24","author":"Raj","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2013.01.032","article-title":"Azide-alkyne cycloaddition en route to 1H-1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation","volume":"62","author":"Raj","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejmech.2017.05.004","article-title":"Recent developments of coumarin-containing derivatives and their anti-tubercular activity","volume":"136","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1568026618666171215101158","article-title":"Recent development of coumarin derivatives as potential antiplasmodial and antimalarial agents","volume":"18","author":"Hu","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib67","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2018.01.017","article-title":"In\u00a0vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs","volume":"145","author":"Yadav","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","article-title":"Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents","volume":"85","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091230","article-title":"Combinatorial synthesis of structurally diverse triazole-bridged flavonoid dimers and trimers","volume":"21","author":"Sum","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.01.047_bib70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2016.02.041","article-title":"Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities","volume":"113","author":"Kant","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trstmh.2007.10.002","article-title":"Potential antimalarial activity of indole alkaloids","volume":"102","author":"Frederich","year":"2008","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2019.01.047_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2017.04.003","article-title":"Indoles as therapeutics of interest in medicinal chemistry: bird's eye view","volume":"134","author":"Chadha","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejmech.2017.03.010","article-title":"Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores","volume":"131","author":"Deveder","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10822-018-0102-5","article-title":"Structure-based drug design, synthesis and biological assays of P.\u00a0falciparum Atg3-Atg8 protein-protein interaction inhibitors","volume":"32","author":"Villa","year":"2018","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2019.01.047_bib75","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.bmc.2005.02.017","article-title":"1,2,4-Triazino-[5,6b]indole derivatives: effects of the trifluoromethyl group on in\u00a0vitro antimalarial activity","volume":"13","author":"Kgokong","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/ci2005516","article-title":"Computer-aided drug design of falcipain inhibitors: virtual screening, structure-activity relationships, hydration site thermodynamics, and reactivity analysis","volume":"52","author":"Shah","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.01.047_bib77","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejmech.2014.10.024","article-title":"1H-1,2,3-triazole tethered isatin-ferrocene conjugates: synthesis and in\u00a0vitro antimalarial evaluation","volume":"87","author":"Kuamr","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib78","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.bmcl.2010.02.017","article-title":"Comparison of the antiplasmodial and falcipain-2 inhibitory activity of \u03b2-amino alcohol thiolactone-chalcone and isatin-chalcone hybrids","volume":"20","author":"Hans","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib79","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.mib.2010.09.008","article-title":"The future of the \u03b2-lactams","volume":"13","author":"Llarrull","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.01.047_bib80","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bmcl.2005.01.011","article-title":"Design, synthesis and biological evaluation of novel bicyclic \u03b2-lactams as potential antimalarials","volume":"15","author":"Nivsarkar","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib81","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.bmcl.2011.05.119","article-title":"Antiplasmodial and cytotoxicity evaluation of 3-functionalized 2-azetidinone derivatives","volume":"21","author":"Singh","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.01.047_bib82","first-page":"311","article-title":"Design, synthesis, activity evaluation and QSAR studies of novel antimalarial 1,2,3-triazolo-\u03b2-lactam derivatives","volume":"15","author":"Jarrahpour","year":"2016","journal-title":"J.\u00a0Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.01.047_bib83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00044-015-1474-x","article-title":"Synthesis and biological evaluation of some new \u03b2-lactam-triazole hybrids","volume":"25","author":"Jarrahpour","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.01.047_bib84","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2014.08.053","article-title":"1H-1,2,3-triazole tethered mono- and bis-ferrocenylchalcone-\u03b2-lactam conjugates: synthesis and antimalarial evaluation","volume":"86","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib85","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1021\/ja402326z","article-title":"Bifunctional unnatural sialic acids for dual metabolic labeling of cell-surface sialylated glycans","volume":"135","author":"Feng","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.01.047_bib86","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1021\/ja303853y","article-title":"Cell-selective mataboloc glycan labeling based ligand-targeted liposomes","volume":"134","author":"Xie","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.01.047_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2014.09.060","article-title":"Preparation and antimalarial activity of a novel class of carbohydrate-derived, fused thiochromans","volume":"87","author":"Kinfe","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.13408","article-title":"Design, synthesis, and antiplasmodial evaluation of a series of novel sulfoximine analogues of carbohydrate-based thiochromans","author":"Chizema","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.01.047_bib89","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1016\/j.bmc.2005.04.043","article-title":"New ether diglycosides from Matayba guianensis with antiplasmodial activity","volume":"13","author":"Mesquita","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib90","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2016.05.069","article-title":"Polyvalent effect enhances diglycosidic antiplasmodial activity","volume":"121","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib91","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ejmech.2018.06.042","article-title":"Synthesis and antiplasmodial activity of glyco-conjugate hybrids of phenylhydrazono-indolinones and glycosylated 1,2,3-triazolylmethyl-indoline-2,3-diones","volume":"155","author":"Thakur","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib92","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ccr.2007.08.001","article-title":"Traversing the coordination chemistry and chemical biology of hydroxamic acids","volume":"252","author":"Codd","year":"2008","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.01.047_bib93","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2017.04.013","article-title":"Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors","volume":"135","author":"Vreese","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bmc.2009.10.042","article-title":"Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group","volume":"18","author":"Patil","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib95","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/jm701606b","article-title":"A\u00a0series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum","volume":"51","author":"Chen","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib96","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2016.11.019","article-title":"An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold","volume":"126","author":"Cherukupalli","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib97","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejmech.2017.12.069","article-title":"Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis","volume":"145","author":"Purushothaman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib98","doi-asserted-by":"crossref","first-page":"41827","DOI":"10.1074\/jbc.M206854200","article-title":"Malarial dehydroorotate dehydrogenase substrate and inhibitor specificity","volume":"277","author":"Baldwin","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib99","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib100","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib101","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/jm801343r","article-title":"Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice","volume":"52","author":"Gujjar","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib102","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite, Plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib103","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/jm200265b","article-title":"Lead-optimization of aryl and aralkyl amine based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in mice","volume":"54","author":"Gujjar","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib104","doi-asserted-by":"crossref","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","article-title":"Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds","volume":"284","author":"Deng","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib105","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm500481t","article-title":"Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors","volume":"57","author":"Deng","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib106","doi-asserted-by":"crossref","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A\u00a0long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2019.01.047_bib107","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/acs.jmedchem.6b00275","article-title":"Tetrahydro-2-naphthyl and 2-indanyl triazolopyrimidines targeting Plasmodium falciparum dihydroorotate dehydrogenase display potent and selective antimalarial activity","volume":"59","author":"Kokkonda","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib108","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/15701808113109990017","article-title":"Synthesis and in\u00a0vivo antimalarial activity of novel derivatives of 6-mercaptopurine","volume":"10","author":"Soares","year":"2013","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2019.01.047_bib109","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.02.021","article-title":"Pyrimidine-chloroquinoline hybrids: synthesis and antiplasmodial activity","volume":"148","author":"Chopra","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopha.2010.10.013","article-title":"Thiopurine derivatives containing triazole and steroid: synthesis, antimalarial and antileishmanial activities","volume":"65","author":"Corrales","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.01.047_bib111","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1155\/2008\/394737","article-title":"Syntheses of 1,2,4-triazole derivatives and their biological activity","volume":"5","author":"Havaldar","year":"2008","journal-title":"E.\u00a0J. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib112","first-page":"231","article-title":"Synthesis of triazole-linked 2-trichloromethylquinazolines and exploration of their efficacy against P.\u00a0falciparum","volume":"66","author":"Hamann","year":"2013","journal-title":"S.\u00a0Afr. J. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib113","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","article-title":"Recent advances of imidazole-containing derivatives as anti-tubercular activity","volume":"150","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib114","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib115","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00044-018-2146-4","article-title":"Evaluation of triazole and isoxazole derivatives as potential antiinfective agents","volume":"27","author":"Tarawneh","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.01.047_bib116","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/c1md00129a","article-title":"Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors","volume":"2","author":"Shah","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2019.01.047_bib117","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1039\/C8NJ00670A","article-title":"Microwave assisted one-pot synthetic route to imidazo[1,2-a]pyrimidine derivatives of imidazo\/triazole clubbed pyrazole and their pharmacological screening","volume":"42","author":"Prasad","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib118","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/jm901178d","article-title":"Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles","volume":"53","author":"Bakunov","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib119","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/cmdc.201100265","article-title":"Synthesis and antimalarial activities of a diverse set of triazole-containing furamidine analogues","volume":"6","author":"Berger","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.01.047_bib120","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.3390\/molecules16098083","article-title":"Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes","volume":"16","author":"Boechat","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.01.047_bib121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in\u00a0vitro activity, docking to PfDHODH and SAR of lapachol-based compounds","volume":"145","author":"Brandao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib122","first-page":"128","article-title":"Synthesis of novel sulfonamides as potential antibacterial, antifungal and antimalarial agents","volume":"54","author":"Mistry","year":"2015","journal-title":"Indian J. Chem. B"},{"key":"10.1016\/j.ejmech.2019.01.047_bib123","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/ml200135p","article-title":"An invitation to open innovation in malaria drug discovery: 47 Quality starting points from the TCAMS","volume":"2","author":"Calderon","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.01.047_bib124","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1021\/acs.jmedchem.5b00434","article-title":"Carbamoyl triazoles, known serine protease inhibitors, are a potent new class of antimalarials","volume":"58","author":"McConville","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/jm301577q","article-title":"Alpha-heteroatom derivatized analogues of 3-(acetylhydroxyamino)propyl phosphonic acid (FR900098) as antimalarials","volume":"56","author":"Verbrugghen","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib126","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/1570180812666141111235301","article-title":"Design, synthesis and biological evaluation of novel fluorinated heterocyclic hybrid molecules based on triazole & quinoxaline scaffolds lead to highly potent antimalarials and antibacterials","volume":"12","author":"Shekhar","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2019.01.047_bib127","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800086","article-title":"Synthesis and glutathione reductase inhibitory properties of 5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one's aryl Schiff base derivatives","volume":"351","author":"Balaydin","year":"2018","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2019.01.047_bib128","first-page":"130","article-title":"Synthesis and biological evaluation of novel thiosemicarbazone-triazole hybrid compounds as antimalarial agents","volume":"66","author":"Kinfe","year":"2013","journal-title":"S.\u00a0Afr. J. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejmech.2015.12.038","article-title":"Identification of \u03b2-amino alcohol grafted 1,4,5 trisubstituted 1,2,3-triazoles as potent antimalarial agents","volume":"109","author":"Devender","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800151","article-title":"Azole-based non-peptidomimetic plasmepsin inhibitors","volume":"351","author":"Kinena","year":"2018","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.ejmech.2019.01.047_bib131","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1128\/AAC.01436-16","article-title":"Triazole substitution of a labile amide bond stabilizes pantothenamides and improves their antiplasmodial potency","volume":"60","author":"Howieson","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.01.047_bib132","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.bmc.2017.05.054","article-title":"1,2,4-Triazole and 1,3,4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities","volume":"25","author":"Thakkar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib133","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/ml2001517","article-title":"Cyclopropyl carboxamides: a new oral antimalarial series derived from the tres cantos anti-malarial set (TCAMS)","volume":"2","author":"Rueda","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.01.047_bib134","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bmc.2016.10.029","article-title":"Synthesis and evaluation of naphthyl bearing 1,2,3-triazole analogs as antiplasmodial agents, cytotoxicity and docking studies","volume":"25","author":"Balabadra","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/cmdc.201700786","article-title":"Development of a focused library of triazole-linked privileged-structure-based conjugates leading to the discovery of novel phenotypic hits against protozoan parasitic pnfections","volume":"13","author":"Uliassi","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.01.047_bib136","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jfluchem.2011.05.011","article-title":"Synthesis of novel 1,4-disubsituted-[1,2,3]-triazole-derived \u03b2-aminovinyl trifluoromethylated ketones and their copper(II) complexes","volume":"132","author":"Chopin","year":"2011","journal-title":"J.\u00a0Fluorine Chem."},{"key":"10.1016\/j.ejmech.2019.01.047_bib137","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00044-017-2072-x","article-title":"Convenient synthesis, antimalarial and antimicrobial potential of thioethereal 1,4-disubstituted 1,2,3-triazoles with ester functionality","volume":"27","author":"Kaushik","year":"2018","journal-title":"Med. Chem. Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419300595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T20:28:54Z","timestamp":1662841734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419300595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":137,"alternative-id":["S0223523419300595"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.047","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triazole derivatives and their antiplasmodial and antimalarial activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.01.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}